Exploring the impact of a celebrity health announcement on public awareness
the ONA take:
Breast cancer treatment options received considerable media attention when Angelina Jolie revealed she had undergone prophylactic double mastectomy for BRCA1 positivity.
In this first study of media-related impact on public awareness, these authors surveyed two female population-matched cohorts of 1,000 participants each, ages 18 to 65 years, in two polls. Poll 1 was taken in March 2013, before Ms. Jolie’s announcement in May 2013; poll 2 was taken in June 2013, after the announcement.
The authors report a significant increase in awareness of reconstructive breast surgery after breast cancer-related mastectomy. In particular, awareness of autologous tissue and single-stage reconstructions was higher in poll 2, with approximately 20% of women in poll 2 indicating that the media coverage affected their interest in the disease.
This prospective study demonstrated a statistically significant impact of a celebrity announcement on public awareness of breast cancer treatment options. To the best of the authors’ knowledge, theirs is the first study to do so.
The results highlight the importance of media-related impact in improving public awareness of a specific disease.
Breast cancer treatment options received considerable media attention when Angelina Jolie revealed she had undergone double mastectomy.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Some Early Breast Cancer Patients Should Have Breast Conservation Instead of Mastectomy
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Targeting AR Mutations Promising in Metastatic Prostate Cancer
- GUCS 2017: Early Immunotherapy Discontinuation in mRCC
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Myalgia-arthralgia Syndrome Associated With Taxanes in Patients with Breast Cancer
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|